August 13, 2012

An experimental drug therapy under development by Novartis for liver transplant patients appears to provide similar efficacy and better kidney function, compared with a drug made by Astellas Pharma, according to results of a late-stage clinical trial.

August 10, 2012

BioScrip on Wednesday posted $155.9 million in second-quarter revenue, up 18.5% compared with the prior year.

August 9, 2012

The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.

August 9, 2012

Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

August 9, 2012

Breaking into the complex world of specialty medicines means navigating big challenges. Still, there’s a clear role in specialty Rx for independent and small-chain pharmacy owners, industry leaders assert.

August 9, 2012

Drug maker Sagent Pharmaceuticals has launched a generic chemotherapy drug, the company said Thursday.

August 8, 2012

The Food and Drug Administration has approved an oral painkiller made by Perrigo, the drug maker said Wednesday.

August 8, 2012

Drug makers Teva Pharmaceutical Industries and Active Biotech will start a third late-stage clinical trial of an experimental drug for treating multiple sclerosis, the companies said Wednesday.

August 6, 2012

The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

August 3, 2012

Mylan and Gilead Sciences have made an agreement under which Mylan will have rights to produce and market generic versions of Gilead drugs for HIV and AIDS in developing countries.

August 2, 2012

Teva Pharmaceutical Industries has named Carlo De Notaristefani as president and CEO of global operations and Aharon "Arik" Yaari as EVP community and institutional affairs, the Israeli drug maker said Thursday.

July 31, 2012

Abon Pharmaceuticals is challenging the patent protection on an injected drug used to treat leukemia in children and adolescents, the company said Tuesday.

July 31, 2012

CoramRx Specialty Pharmacy Services has received specialty pharmacy accreditation from URAC, the company announced.

July 30, 2012

A provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other specialty pharmacy medications has been awarded specialty pharmacy accreditation from URAC.

July 27, 2012

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 26, 2012

Qualitest Pharmaceuticals announced that it has received approval from the Food and Drug Administration for its generic version of an epilepsy treatment.

July 25, 2012

A division of Becton, Dickinson and Co. has introduced a thin-walled needle for injecting highly viscous drug formulations.

July 24, 2012

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.

July 24, 2012

A new organization aims to be an independent group to certify specialty pharmacists.

July 23, 2012

Nearly all healthcare professionals are satisfied with Diplomat Specialty Pharmacy's services, according to results of a survey released Monday.

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

July 23, 2012

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

July 17, 2012

A company that develops software for the specialty pharmacy and similar industries has integrated Armada Health Care's prior authorization system into its product.

July 17, 2012

A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.